Radical Numerics Uses AI-Designed Virus in 1st Human Treatment for Deadly Bacterial Infection
Updated
Updated · The New York Times · Oct 20
Radical Numerics Uses AI-Designed Virus in 1st Human Treatment for Deadly Bacterial Infection
2 articles · Updated · The New York Times · Oct 20
Summary
Scientists said Tuesday they administered an AI-designed phage to a human patient for the first time, aiming to treat a deadly bacterial infection.
Radical Numerics, the start-up behind the virus, said the phage was engineered to attack the bacteria causing the infection and that the treatment was authorized by the FDA.
The company withheld the patient's identity and the doctors running the trial, citing confidentiality requirements from its clinical partners.
A technical report describing the virus was posted on Radical Numerics' website, but it has not been peer reviewed or published in a scientific journal.
How exactly does an AI-designed virus behave inside the human body compared to naturally occurring bacteriophages during a severe infection?
Will the extreme specificity of AI-generated phages make them too expensive and logistically complex to replace standard antibiotics for the general public?
What specific biosecurity safeguards prevent the generative AI used for this breakthrough from being weaponized to create dangerous human pathogens?